ASPEN PHARMACAR/ADR (OTCMKTS:APNHY) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Monday, Zacks.com reports.

According to Zacks, “Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa. “

Separately, ValuEngine upgraded ASPEN PHARMACAR/ADR from a “sell” rating to a “hold” rating in a research note on Wednesday, October 2nd.

Shares of OTCMKTS APNHY traded up $0.22 during midday trading on Monday, hitting $7.11. 8,343 shares of the stock traded hands, compared to its average volume of 53,513. The firm has a 50-day moving average of $5.95 and a two-hundred day moving average of $6.46. The firm has a market capitalization of $3.09 billion, a P/E ratio of 5.69, a PEG ratio of 1.02 and a beta of 1.10. ASPEN PHARMACAR/ADR has a one year low of $4.14 and a one year high of $11.79.

ASPEN PHARMACAR/ADR Company Profile

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. The company offers various oral solid dose, liquids, semi-solids, steriles, biogicals, active pharmaceutical ingredients, and infant nutritional products.

Read More: How interest rates affect municipal bond prices

Get a free copy of the Zacks research report on ASPEN PHARMACAR/ADR (APNHY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for ASPEN PHARMACAR/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASPEN PHARMACAR/ADR and related companies with MarketBeat.com's FREE daily email newsletter.